Keyphrases
Acute Coronary Syndrome
100%
ST-elevation Myocardial Infarction (STEMI)
84%
Acute Myocardial Infarction
79%
Left Ventricular Remodeling
52%
Soluble Suppression of Tumorigenicity 2 (sST2)
50%
Global Longitudinal Strain
50%
Carotid Intima-media Thickness (cIMT)
42%
Surabaya
37%
Myocardial Infarction Patients
37%
General Hospital
34%
Indonesia
28%
Troponin
28%
Soot Particulates
25%
Wall Motion Score Index
25%
East Java Indonesia
25%
Social Impact
25%
Economic Impact
25%
Nine-level
25%
Platelet Response
25%
High On-treatment Platelet Reactivity
25%
Post-percutaneous Coronary Intervention
25%
Platelet Aggregometry
25%
ACE Inhibitor Therapy
25%
Left-behind Parents
25%
Female Migration
25%
Mikania Micrantha
25%
Exposure to Air Pollution
25%
Dementia Model
25%
Polycythemia Vera
25%
Venous Thrombosis
25%
Party Development
25%
Arterial Thrombosis
25%
25-hydroxyvitamin D Levels
25%
Cardiology
25%
Echocardiography
25%
CD40 Ligand (CD40L)
25%
Asymmetric Dimethylarginine
25%
Heart Failure Patients
25%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
25%
Two-dimensional Speckle Tracking Echocardiography
25%
Leukocytosis
25%
System Disruption
25%
Vascular Cell Adhesion molecule-1 (VCAM-1)
25%
Ticagrelor
25%
Post-myocardial Infarction
25%
Low-dose Effects
25%
Acute Heart Failure
25%
Light Transmission
25%
Cardiovascular System
25%
Cardiovascular Risk
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
58%
Acute Coronary Syndrome
50%
Heart Infarction
31%
ST Segment Elevation Myocardial Infarction
30%
Mikania
25%
Galectin 3
25%
CD40 Ligand
25%
Acetic Acid Ethyl Ester
25%
Vascular Cell Adhesion Molecule 1
25%
Acute Heart Failure
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Cardiovascular Risk
25%
Gelatinase B
25%
End Stage Renal Disease
25%
N(g),n(g) Dimethylarginine
25%
6 N,n' Dimethylarginine
25%
Myeloperoxidase
22%
Hemodialysis
17%
Disease
16%
Non ST Segment Elevation Myocardial Infarction
14%
Thorax Pain
13%
Atherosclerosis
12%
Biological Marker
12%
Heart Ventricle Remodeling
11%
Heart Disease
11%
Homocysteine
10%
Observational Study
10%
Enzyme-Linked Immunosorbent Assay
9%
Inflammation
8%
Nootropic Agent
8%
Alloxan
8%
Antidiabetic Agent
8%
Glibenclamide
8%
Butanol
8%
Hexane
8%
Neuroprotection
8%
Unstable Angina Pectoris
8%
Heart Muscle Fibrosis
6%
Ischemia
6%
Cross-Sectional Study
6%
Immunoassay
6%
Congestive Heart Failure
5%